Lee recalls that after retiring from the corporate world, he was living in Perth when a group of Australian scientists approached him for support for a small study on fentanyl, a pain relief medication commonly used during labour and delivery.
You might expect a pharmaceutical company founder to have a background in science or medicine. Instead, Catalist-listed iX Biopharma (SGX:42C
) was founded by Eddy Lee, who spent most of his career in unrelated fields, from hospitality to telecommunications.
Instead of a formal education in science or something related, Lee earned his business degree from Australia’s Curtin University. Over the years, Lee, the chairman and CEO of iX Biopharma, held management roles at companies, including Genting Group in Malaysia, CDL Hotel International in Hong Kong, Star Cruises in Singapore and Amcon Telecommunications in Australia.
